NiftyInvest

Cipla: co unit cipla health completes purchase of cosmetics & personal care business from ivia beaute

Macrotech developers: co says nclt, has accorded its approval to the resolution plan of the co in relation to the cirp of v hotels || co says under the said resolution plan, co will pay ₹900 crore in tranches over a period of 270 days

Ami organics: co approved raising of funds worth upto 991m rupees via issuance of shares on private placement basis

Adani enterprises: co unit adani global completed acquisition of 49% stake of adani esyasoft smart solutions from esyasoft holding

Hcltech: co exec says broader macro continues to be quite volatile || co exec says cautiously optimistic, assume a similar macro environment that we saw in fy24 to also be there for predominant part of fy25

Hcl tech: state bank of india partners with hclsoftware to digitally transform customer engagement

Apollo hospitals enterprise: ahel would continue to remain largest controlling shareholder with at least 59.2% stake || merger with keimed is estimated to be eps accretive from year 1

Apollo hospitals enterprise: advent shall invest in compulsory convertible instruments over 2 tranches to secure 12.1% stake in merged entity || advent valuing combined entity at an enterprise value of 224.81b rupees; keimed shareholders would hold a maximum of 25.7% stake in combined entity

Apollo hospitals enterprise: co says approval for primary investment of 24.75b rupees by rasmeli into apollo healthco || apollo 2417 to raise 24.75b rupees from advent international; to merge keimed with apollo 2417

Mawana sugars: co says closed crushing ops for the season 2023-24 in its unit mawana sugar works

Mastek: co has recommended a final dividend of 12 rupees per share

Mastek: q4 ebit 976.2m rupees vs 1.12b (qoq) || q4 ebit margin 12.52% vs 14.24% (qoq)

Mastek: q4 ebitda 1.25b rupees vs 1.34b (qoq) || q4 ebitda margin 16.05% vs 17.03% (qoq)

Mastek: q4 cons net profit 920.6m rupees vs 753m (qoq) || q4 revenue 7.8b rupees vs 7.84b (qoq)

New delhi television: q4 ebitda loss 155.8m rupees vs loss 147.5m (yoy) || q4 ebitda margin -14.63% vs -22.03% (yoy)

New delhi television: q4 cons net loss 84.6m rupees vs profit 5.9m (yoy); loss 95.5m (qoq) || q4 revenue 1.07b rupees vs 669.6m (yoy); 979.5m (qoq)

Usha martin: co recommended a final dividend of 2.75 rupees per share

Usha martin: q4 ebitda 1.52b rupees vs 1.54b (yoy) || q4 ebitda margin 18.28% vs 18% (yoy)

Usha martin: q4 cons net profit 1.06b rupees vs 1.05b (yoy); 1.08b (qoq) || q4 revenue 8.29b rupees vs 8.55b (yoy); 7.97b (qoq)

Mahindra lifespace developers: co recommended final dividend of 2.65 rupees per share